 |
Also known as: Idamycin, Idamycin PFS
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Idarubicin.
No reviews have yet been submitted. Be the first to review this drug.
The chemotherapy used to treat a form of adult leukemia sets a trap that can result in the return of the disease within years, a new study suggests. The...
Cylene Pharmaceuticals, Inc. announced today that two of its first-in-class agents, both inhibitors of newly-validated targets, have demonstrated...
Clinical Data Show Promising Effects of AVL-292 in Patients with Chronic Lymphocytic Leukemia Preclinical Data Demonstrate Potential of AVL-292 in...
Dec 12, 2011 - Plexxikon Inc., a member of Daiichi Sankyo Group, today announced scientific findings from preclinical studies showing that treatment with...
Dec 5, 2011 - Sequenta, Inc., will present the results from five studies at the American Society of Hematology (ASH) annual meeting in San Diego, CA,...
Looking for answers? Ask a question or go join the idarubicin support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
